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CIZ1 is a nuclear protein involved in DNA replication and is also implicated in human diseases
including cancers. To gain an insight into its function in vivo, we generated mice lacking Ciz1.
Ciz1-deﬁcient (Ciz1/) mice grew without any obvious abnormalities, and Ciz1/mouse embryonic
ﬁbroblasts (MEFs) did not show any defects in cell cycle status, cell growth, and DNA damage
response. However, Ciz1/MEFs were sensitive to hydroxyurea-mediated replication stress and sus-
ceptible to oncogene-induced cellular transformation. In addition, Ciz1/ mice developed various
types of leukemias by retroviral insertional mutagenesis. These results indicate that CIZ1 functions
as a tumor suppressor in vivo.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In higher eukaryotes, cell cycle regulation is tightly controlled
by cyclin-dependent kinases (CDKs) [1–3]. CDKs are activated by
the association with their cognate cyclins and also inactivated by
CDK inhibitors (CDKIs) [1–3]. The p21Cip1/Waf1 protein is a CDKI
that constitutes the Cip/Kip CDKI family together with two struc-
turally related proteins, p27Kip1, and p57Kip2 [2,4]. Through their
N-terminal homologous sequences, these CDKIs bind to various
CDK/cyclin complexes and inhibit the CDK activity [2,4]. In addi-
tion, p21Cip1/Waf1 binds to proliferating cell nuclear antigen (PCNA)
and competes with PCNA-binding proteins, such as DNA polymer-
ase, which directly leads to inhibition of DNA synthesis [3]. As a re-
sult, p21Cip1/Waf1 contributes not only to cell cycle arrest, but also
to various physiological and pathological processes, such as senes-
cence, apoptosis, and DNA repair [1]. Notably, p21Cip1/Waf1 func-
tions as a direct target of p53 and contributes to G1 growth
arrest in response to DNA damage [1–3].
To gain an insight into the regulatory system of p21Cip1/Waf1
activation, we performed a modiﬁed yeast two-hybrid screening,isolated a gene for a novel p21Cip1/Waf1-interacting protein and
named it as CIZ1 (Cip1 interacting zinc ﬁnger protein 1) [5]. CIZ1
is ubiquitously expressed and is composed of several different
functional domains, including two glutamine-rich repeats (QD1
and QD2) at the N-terminus, followed by three zinc ﬁnger motifs,
and acidic and Matrin 3 domains [5]. Biochemical analysis revealed
that the N-terminal region of p21Cip1/Waf1 containing the CDK/cy-
clin binding domain interacts with C-terminal region of CIZ1
through the 1st zinc ﬁnger domain [5]. In addition, overexpressed
CIZ1 affected subcellular localization of p21Cip1/Waf1 [5].
Subsequent studies have shown that CIZ1 comprises two func-
tionally distinct domains at the N- and C-termini, which are in-
volved in initiation of DNA replication and anchoring nuclear
matrix, respectively [6–8]. Enforced expression of CIZ1 increased
the number of BrdU-positive cells and stimulated S phase entry,
and in contrast, depletion of CIZ1 by siRNA decreased the number
of BrdU-positive cells, inhibited S phase entry, and suppressed cell
proliferation [6]. In addition, CIZ1 has possible roles as a mediator
between DNA replication factories and chromatin-associated repli-
cation complexes through its C-terminus, suggesting that it is in-
volved in replication fork organization [7]. The DNA replication-
promoting function of CIZ1 was mediated by the association with
cyclins E and A, which subsequently recruited CDK2 and led to
the activation of CDK2 by forming CDK2/cyclin A complex [9].
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Fig. 1. Cell cycle and proliferation analysis. (A) Cell cycle status of Ciz1+/+ and Ciz1/
MEFs. Cell cycle phases were analyzed by FACS. Results shown are representative
of independent experiments using two independently derived MEF lines for each
genotype. (B) Saturation density of Ciz1+/+ and Ciz1/ MEFs. 1  105 cells were
plated in a 10 cm2 dish and allowed to grow. Cell number of triplicate samples
counted at 3, 5, 7, 9, and 11 days are shown as mean ± S.D. (C) Growth curve of
Ciz1+/+ and Ciz1/ MEFs. 3  105 cells at passage 3 were plated and 9  105 cells
were re-plated in every 3 days. Calculated total cell numbers of triplicate samples at
each passage are shown as mean ± S.D.
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ated with various types of human diseases, such as rheumatoid
arthritis [10], Alzheimer’s disease [11], cervical dystonia [12], and
several types of cancers including breast cancer [13,14], medullo-
blastoma [15], Ewing sarcoma and neuroblastoma [16], and lung
cancer [8]. Aberrant expression, splicing variants, and point muta-
tions are identiﬁed in these diseases, strongly suggesting that
deregulated CIZ1 function may be responsible for disease
pathogenesis.
To comprehend the biological signiﬁcance of CIZ1 and to clarify
the role of CIZ1 in disease development, it is necessary to generate
model mice in which Ciz1 is genetically modiﬁed. To achieve this,
we created and analyzed mice lacking Ciz1.
2. Materials and methods
2.1. Construction of a targeting vector and generation of Ciz1-deﬁcient
mice
The detailed procedure for construction of a targeting vector
and generation of Ciz1-deﬁcient mice is described in Supplemen-
tary information. All the mice were kept according to the guide-
lines of the Institute of Laboratory Animal Science, Hiroshima
University.2.2. Irradiation
Freshly prepared mouse embryonic ﬁbroblasts (MEFs) were
irradiated two days after passaging with 10 Gy of c-radiation using
Gammacell 40 Exactor Cesium137 irradiator (Nordion, Ottawa, Can-
ada). Immediately after irradiation, cells were returned to the incu-
bator for recovery until the appropriate time point.
2.3. Immunoblot analysis
Total proteins were separated by electrophoresis on an SDS–
polyacrylamide gel, and then transferred to nylon or PVDF mem-
branes for immunoblot analysis. Membranes were blotted with
the following antibodies: anti-p53-Ser15 (rabbit 92845, Cell sig-
naling, Danvers, MA, USA), anti-phospho H2AX (Ser139; rabbit
07-164, UPSTATE, Lake Placid, NY, USA), anti-p21Cip1/Waf1 (mouse
F-5, Santa Cruz Biotechnology Inc. Santa Cruz, CA, USA), anti-E1A
(sc-25, Santa Cruz), anti-Ras (clone 18/Ras, BD transduction), and
b-actin (mouse AC-74, Sigma–Aldrich, St. Louis, MO, USA). Signals
were detected with ECL Advance Western Blotting Detection kit
(GE Healthcare, UK), according to the manufacturer’s instructions
and were recorded using Hyperﬁlm MP (GE Healthcare, UK).
2.4. Indirect immunoﬂuorescence
For H2AX staining, cells were ﬁxed in 3% paraformaldehyde
phosphate buffered-saline (PBS) for 10 min, permeabilized with
0.5% NP-40 PBS for 10 min, and stained with the anti-phospho
H2AX (Ser139) and Alexa Fluor 488 goat anti-rabbit antibodies
(A-11034 Molecular Probes, Eugene, Oregon USA) and further con-
currently with bisbenzimide H33342 (1 lg/ml; Nacalai tesque,
Kyoto, Japan). For BrdU and PCNA staining, cells were starved for
2 days, activated by D-MEM 20% FBS in the presence of 5 mM
hydroxyurea and arrested in the G1/S phase for 24 h. Cells were
then released from the G1/S arrest by replacing the medium with-
out hydroxyurea and labeled for 1 h at 0 (early S), 4 (mid S), and 7
hs (late S), by adding 0.01 mM BrdU. Cells were grown on cover-
slips and ﬁxed in 3% paraformaldehyde PBS with brief pre-expo-
sure to 0.05% Triton X-100 in PBS. BrdU-staining was performed
after acid denaturation of the DNA with monoclonal antibody
BU-33 (1:100; Sigma–Aldrich). Endogenous PCNA was detected
with monoclonal antibody PC10 (1:100; Santa Cruz). Alexa Fluor
594 goat anti-mouse IgG (1:500; A-11005 Molecular Probes) was
used as the secondary antibodies and the DNA was stained with
bisbenzimide H33342. Images were captured using an epiﬂuores-
cence optics equipped with a CCD camera (BX60 and DP70, Olym-
pus, Tokyo, Japan).
2.5. Hydroxyurea treatment
Exponentially growing cells were plated at 3  103 cells/well
into a 96-well plate, allowed to adhere for 24 h, and exposed to
hydroxyurea at the limited dilutions (0.1 or 0.4 mM). After seven
days, viable cells in the presence and absence of hydroxyurea were
determined using CellTiter-Glo Luminescent Cell Viability Assay
and GloMax 20/20 (Promega, Madison, MI USA), according to the
manufacturer’s instructions.
2.6. Focus formation and soft agar assays
MEFs were transduced with the E1A/H-RasV12 using retroviral
infection. Transduced cells were selected by growth in puromycin
(2 lg/ml) for 3 days and subsequently used for experiments after
several passages. For focus formation assay, cells were plated at
1  104 cells/well in a 6-well plate, allowed to form foci in liquid
culture for 14 days, and foci were ﬁxed and stained with 0.5%
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Fig. 2. ATM activation in Ciz1/ MEFs. (A) Western blots of p53 (phospho-Ser15), c-H2AX (Phospho-Ser139), p21Cip1/Waf1, and b-actin at 0, 0.5, 2, 4, 12 h after 10 Gy
irradiation. (B) Appearance and localization of c-H2AX foci at 0.5 h after 10 Gy irradiation (right upper panels). Nuclei were counterstained using bisbenzimide H33342 that
detects DNA (lower panels). Results shown in A and B are representative of three independent experiments using two independently derived MEF lines for each genotype.
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Fig. 3. Ciz1/ MEFs were sensitive to replication stress and susceptible to cellular
transformation. (A) Viability of cells exposed to different concentrations of
hydroxyurea (0 mM, 0.1 mM, and 0.4 mM). Percentages of viable cells are shown
as the relative ratio with those in 0 mM hydroxyurea (±S.D.). ⁄⁄P < 0.01 (Student’s t-
test). (B) Focus formation assay. Left panel: western blot showing that equal levels
of E1A and Ras proteins were expressed in Ciz1+/+ and Ciz1/ MEFs. Right panel:
photographs of foci stained with 0.5% crystal violet in 20% ethanol. (C) Anchorage-
independent growth in soft agar. Left panel; photographs of colonies. Right panel;
the mean colony number (±S.D.). ⁄⁄P < 0.01 (Student’s t-test).
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described [17] with minor modiﬁcations. Cells were plated at
1.5  104 cells/well in a 12-well plate and allowed to form colonies
for 4 weeks. Visible colonies were counted.
2.7. MOL4070A retrovirus infection
Preparation and infection of retrovirus were performed as de-
scribed [18]. Newborn mice were intraperitoneally inoculated with
100 ll of virus solution containing approximately 1  105 virus
particles.
3. Results
3.1. Generation of Ciz1-deﬁcient mice
Two protein isoforms, full length CIZ1 and a shorter form,
called embryonic CIZ1 (ECIZ1), are produced by using different
translation initiation ATGs that are located in exons 2 and 3,
respectively [6]. In addition, a number of splicing variants are gen-
erated by alternative splicing mechanisms [19]. Thus, to abrogate
CIZ1 function, we aimed to delete exon 5, which is exclusively
used in all the alternatively spliced forms [6,19] and which en-
codes a putative CDK phosphorylation site that plays an essential
role in the DNA replication activity of CIZ1 [6]. To achieve this, we
generated mice in which exon 5 was ﬂanked by two loxP sites and
deleted exon 5 by crossing the mice with CAG-Cre transgenic mice
that express Cre recombinase in fertilized eggs (RIKEN BRC,
RBRC01828; Supplementary Fig. 1A and B). Since we do not have
an antibody to detect CIZ1 protein, we analyzed Ciz1 expression
at the mRNA level by Northern blot. No Ciz1 mRNA expression
was detected in homozygotes (Supplementary Fig. 1C), indicating
that our targeting strategy of the deletion of exon 5 rendered
mRNA instability and resulted in a null mutation of the Ciz1 gene
(hereafter the homozygotes are referred to as Ciz1/ mice).
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Fig. 4. Leukemias in MOL4070A-infected Ciz1/ mice. (A) Survival curves of MOL4070A-infected Ciz1+/+ and Ciz1/ mice (shown as Ciz1+/+/MOL4070A and Ciz1//
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(lower panel). Germline (GL) and rearranged bands are indicated with an arrow and arrowheads, respectively. (D) Flow cytometric analysis of leukemias developed in Ciz1//
MOL4070A mice. No.1 was positive for Thy1.2 but negative for B220, Gr1, and Mac1 and was diagnosed with T-cell acute lymphoblastic leukemia (T-ALL), whereas No. 2 was
positive for Gr1 but negative for Thy1.2, B220, Mac1 and was diagnosed with acute myeloblastic leukemia (AML).
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ﬁbroblasts (MEFs) exhibited normal cell cycle status and proliferative
ability
Ciz1/ mice were born at the expected Mendelian ratio. In
addition, no obvious phenotypic abnormalities were found during
the observation period (1–1.5 years; not shown). This indicated
that CIZ1 deﬁciency did not signiﬁcantly affect embryonic develop-
ment and postnatal growth.
Previous reports demonstrated that CIZ1 is implicated in the
regulation of cell cycle and cell proliferation [6,7,9,13,14]. Thus,
to investigate the effect of CIZ1 deﬁciency on these functions, we
established MEFs from Ciz1+/+ and Ciz1/ littermates and analyzed
their behaviors.
As shown in Fig. 1A, Ciz1+/+ and Ciz1/ MEFs exhibited similar
cell cycle status. In addition, as shown in Fig. 1B and C, Ciz1/
MEFs exhibited similar cell growth ability compared with Ciz1+/+
MEFs. These results indicated that CIZ1 deﬁciency did not signiﬁ-
cantly affect cell cycle and cell proliferation.
3.3. ATM activation in Ciz1/ MEFs
CIZ1 was previously found as a substrate of ATM kinases by a
large-scale proteomic analysis of proteins phosphorylated in
response to DNA damage, and is considered to be implicated in a
DNA damage response (DDR) pathway [20]. We therefore investi-
gated whether Ciz1/ MEFs show altered DDR by c-irradiation.
In general, phosphorylation of ATM downstream targets, a histonevariant H2AX and p53, was detected at 30 min after irradiation,
which subsequently diminished at 12 h. Similar kinetics of phos-
phorylation of these proteins was detected in both Ciz1+/+ and
Ciz1/ MEFs, indicating that activation of ATM was not signiﬁ-
cantly impaired by the absence of CIZ1 (Fig. 2A). Consistently,
appearance and localization of c-H2AX foci were not signiﬁcantly
altered by CIZ1 deﬁciency (Fig. 2B). We also investigated DDR
using the radiomimetic drugs, hydroxyurea (5 mM) and campto-
thecin, but no signiﬁcant difference in phosphorylation of H2AX
and p53 was detected between Ciz1+/+ and Ciz1/ MEFs (not
shown).
3.4. Ciz1/MEFs were sensitive to replicative stress and susceptible to
oncogene-induced transformation
The above ﬁndings demonstrated that CIZ1 deﬁciency in MEFs
does not affect cellular responses to ionizing radiation as well as
proliferation under standard culture conditions. We then investi-
gated the effect of the CIZ1 deﬁciency to replication stress by
exposing the MEFs to low dose of hydroxyurea [21]. As shown in
Fig. 3A, Ciz1/ MEFs were signiﬁcantly sensitive to hydroxyurea
as compared with Ciz1+/+ cells at different concentrations (0.1
and 0.4 mM). These data led us to investigate the role of CIZ1 in
oncogenic transformation. Ciz1+/+ and Ciz1/ MEFs were infected
with retroviruses expressing adenovirus E1A oncogene and consti-
tutive active H-RasV12 (E1A/Ras) [17]. Interestingly, in conditions
in which similar levels of E1A and H-RasV12 were expressed in
both types of cells, Ciz1/ MEFs were more susceptible to E1A/
Table 1
Characteristics of Ciz1//MOL4070A leukemic mice.
Mouse
no.
Age at disease
(month)
PB parameters Macroscopica tumor
sites
Surface markerb
analysis
Gene
rearrangementsc
Diagnosisd
WBC (103/
ml)
Hb (g/
dL)
Plt (104/
ml)
IgH TCRb
1 8.4 27.7 12.9 18.8 Spl Thy1.2(+), B220() G/G G/R ALL
Gr.1(), Mac1(+)
2 8.5 28.8 8.0 62.1 Spl Thy1.2(), B220() G/G G/G AML
Gr.1(+), Mac1(+)
3 9.0 4.5 16.1 79.9 Thy, Spl Thy1.2(+), B220() R/R R/R ALL
Gr.1(), Mac1()
4 9.5 21.6 13.0 44.1 Thy, Spl, LN Thy1.2(+), B220() G/G G/R ALL
Gr.1(), Mac1()
5 10.2 6.1 7.4 23.2 Thy, Spl Thy1.2(+), B220() R/R R/R ALL
Gr.1(), Mac1()
6 10.5 15.5 3.3 92.8 Spl N.D. G/G G/G AML or
AUL
7 11.5 36.4 12.9 25.1 Thy, Spl Thy1.2(+), B220() G/R G/R ALL
Gr.1(), Mac1()
8 12.8 3.5 10.7 76.5 Thy, Spl, LN Thy1.2(), B220(+) G/G G/R ALL
Gr.1(), Mac1()
9 13.0 3.3 14.2 59.5 Spl Thy1.2(), B220() G/G G/G AUL
Gr.1(), Mac1()
10 13.5 97.1 8.0 32.2 Spl Thy1.2(+), B220(+) G/G G/R ALL
Gr.1(), Mac1()
a Thy, thymus; Spl, spleen; LN, lymph node.
b N.D., not done.
c G, germline; R, rearranged.
d ALL, acute lymphoblastic leukemia; AML, acute myeloblastic leukemia; AUL, acute undifferentiated leukemia.
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Fig. 5. Hypothetical model of tumor suppressive properties of CIZ1. (A) Proposed function of CIZ1 in DNA replication. Previous reports have shown that CIZ1 promotes
initiation of DNA replication as well as enters DNA replication factories involved in DNA replication-coupled events [6,7,9]. (B) Reported cancer-related CIZ1 variants retain
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deﬁcient setting, cells show enhanced transformation activity possibly by the mechanism reminiscent of those observed in cancer-related variants.
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focus formation (Fig. 3B). In addition, Ras/E1A-transduced Ciz1/
MEFs generated increased number of colonies as compared with
Ras/E1A-transduced Ciz1+/+ MEFs in anchorage-independent cell
growth assay (Fig. 3C). These results indicate that CIZ1 deﬁciency
promotes transformation in primary cells.3.5. Ciz1/ mice developed various types of leukemia by retrovirus
insertional mutagenesis
The above results indicated that CIZ1 deﬁciency rendered cells
sensitive to oncogenic transformation. To examine whether
Ciz1/ mice are susceptible to tumor development, we performed
retrovirus-mediated insertional mutagenesis [18,22]. Ciz1+/+ and
1534 R. Nishibe et al. / FEBS Letters 587 (2013) 1529–1535Ciz1/ neonates were infected with MOL4070A, which is capable
for inducing myeloid and lymphoid leukemias [23], and disease
development was observed.
Interestingly, as shown in Fig. 4A, while MOL4070A-infected
Ciz1+/+ mice did not exhibit any hematopoietic diseases, all the
MOL4070A-infected Ciz1/ mice developed leukemias within
1 year after birth. Macroscopically, the leukemic mice exclusively
exhibited splenomegaly (Fig. 4B, left panel), which were frequently
associatedwith thymic enlargement and/or lymph node (LN) swell-
ing (not shown). Leukemic cells proliferated in the peripheral blood
(Fig. 4B, right panel) and inﬁltrated the liver, spleen, LNs, and other
tissues (not shown). To determine the lineage of the leukemia cells,
ﬂow cytometric and gene rearrangement analyses were performed.
As shown in Fig. 4C, 7 of 10 leukemic samples (No. 1, 3, 4, 5, 7, 8, and
10) carried rearrangements in TCRb and/or IgH loci in association
with the expression of Thy1.2 and/or B220 (see Table 1), and were
diagnosed as acute lymphoblastic leukemia (ALL). The remaining
three mice exhibited germline patterns in both TCRb and IgH loci,
and one (No. 2) was positive for both Gr1 and Mac1 and diagnosed
with acute myeloid leukemia (AML; Fig. 4C and Table 1), another
(No. 9) was negative for all the surface antigens and was diagnosed
with acute undifferentiated leukemia (AUL), and in the last one (No.
6), we were unable to perform FACS analysis because of autolysis
after death and it was considered to have suffered AML or AUL.
The results of gene rearrangement analysis for TCRb and IgH are
shown in Fig. 4C, and the representative results of ﬂow cytometric
analysis forALL andAMLcases (Nos. 1 and2, respectively) are shown
in Fig. 4D. The characteristics of the leukemic mice are summarized
inTable 1. These results indicated thatCiz1/micewere susceptible
to tumorigenesis and developed various types of leukemias.
4. Discussion
In this report, we analyzed the biological function of CIZ1 by gen-
eratingmice deﬁcient in Ciz1 (Supplementary Fig. 1). Previous stud-
ies showed that CIZ1 is involved in initiation of DNA replication,
DNA replicative factory organization and cell cycle progression
[6,7,9]. These ﬁndings led us to believe that deﬁciency of CIZ1
may affect early developmental processes including embryogene-
sis. However, Ciz1/ mice were born normal and developed with-
out any obvious phenotypical defects (not shown). In addition,
Ciz1/ MEFs exhibited normal cell cycle status and proliferative
potentials (Fig. 1). Thus, our study demonstrated that although
CIZ1 functions as a component of cell cyclemachinery, its deﬁciency
does not signiﬁcantly affect cell cycle regulation. The reason is un-
clear, but the most probable explanation is that other molecules
possessing CIZ1-related function compensate for the absence of
CIZ1. In addition, we demonstrated that CIZ1 deﬁciency did not af-
fect DNA damage-induced c-H2AX phosphorylation and p53-in-
duced p21 expression (Fig. 2). A previous report showed that
CIZ1-mediated cell cycle regulation was not affected by p21Cip1/
Waf1 expression status [6], and although CIZ1 and p21Cip1/Waf1 can
associate with each other[5], their biological roles may be indepen-
dent. Further studies will be required to clarify the functional rela-
tionship between CIZ1 and p21Cip1/Waf1.
Altered expression of CIZ1 has been reported to be associated
with human diseases, especially in cancers [8,13–16]. Generation
of an aberrant transcript lacking exon 4 was reported in Ewing sar-
coma and neuroblastoma specimens [16]. In addition, expression of
a splicing variant lacking exons 8–12 was preferentially detected
with various types of cancer cells [24]. Furthermore, a recent study
demonstrated a variant type of Ciz1, in which a part of the nuclear
matrix anchor domainwasmissing, as a functionally relevant driver
of cell proliferation in human lung cancer [8]. Thus, deﬁciency of
functional domain(s) of CIZ1 is presumed to be involved in carcino-
genesis. We examined the sensitivity of Ciz1/MEFs to replicationstress by treating the cells with hydroxyurea. As shown in Fig. 3A,
Ciz1/ MEFs were highly sensitive to different concentrations of
hydroxyurea, strongly suggesting that Ciz1/MEFs possess a defect
in the DNA repair process. These ﬁndings prompted us to examine
possible tumor suppressive activity of CIZ1. Upon introduction of
activated Ras along with E1A, Ciz1/ MEFs formed a signiﬁcantly
higher number of foci and colonies than Ciz1+/+ cells (Fig. 3B and
C). In addition, infection of replication-competent retrovirus in-
duced various types of leukemias in Ciz1/ mice, while no tumor
was observed in Ciz1+/+ littermates during the observation period
(Fig. 4 and Table 1). These results indicate that CIZ1 deﬁciency ren-
ders cells susceptible to oncogenic transformation and demonstrate
that CIZ1 functions as an anti-oncogene in vivo.
According to previous reports, CIZ1 is proposed to maintain
proper cell division by promoting DNA replication as well as by
forming spatially-restricted subnuclear foci containing DNA repli-
cation factory [6,7,9] (Fig. 5A). Cancer-related exon 4-lacking Ciz1
and exon 14b Ciz1 variants retain the initiation of DNA replication
but fail to form spatially-restricted foci [8,16] (Fig. 5B). To examine
the effect of CIZ1 deﬁciency on the integrity of DNA replication fac-
tories, Ciz1+/+ and Ciz1/MEFs in early, mid and late S phases were
immunoﬂuorescently stained with antibodies against BrdU and
PCNA. As shown in Supplementary Fig. 2, no obvious difference
was observed between both types of cells in any of these cell phases,
indicating that CIZ1 does not directly contribute to the localization
or global structure of DNA replication factories. Thus, we consider
the possibility that CIZ1 deﬁciency may enhance transformation
through affecting DNA replication ﬁdelity, as observed in cases of
delta-exon 4 and exon 14b Ciz1 variants (Fig. 5C and D). Our results
highlight tumor suppressive properties of CIZ1 in vivo, and further
studies will provide a clue underlying the precise mechanism(s) of
how of CIZ1 contributes to cancer as well as other human diseases.
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